<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2004-8-3-48-51</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-850</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ. КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES. CLINICAL INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>ВЛИЯНИЕ ПОКАЗАТЕЛЕЙ ЛИПИДНОГО СПЕКТРА НА ЭНДОТЕЛИЙ-ЗАВИСИМУЮ И ЭНДОТЕЛИЙ-НЕЗАВИСИМУЮ ВАЗОДИЛЯТАЦИЮ У БОЛЬНЫХ С РАЗЛИЧНОЙ СТАДИЕЙ ХРОНИЧЕСКОЙ ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ</article-title><trans-title-group xml:lang="en"><trans-title>THE INFLUENCE OF LIPID SPECTRUM INDICES ON THE ENDOTHELIUM! DEPENDENT AND ENDOTHELIUM-INDEPENDENT VASODILATATION IN PATIENTS WITH DIFFERENT STAGES OF CHRONIC RENAL FAILURE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жданова</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhdanova</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра пропедевтики внутренних болезней</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Назаров</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nazarov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра пропедевтики внутренних болезней</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шалаев</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shalaev</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра пропедевтики внутренних болезней</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мелях</surname><given-names>С. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Melyakh</surname><given-names>S. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра пропедевтики внутренних болезней</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Уральская государственная медицинская академия, Центр болезней почек и диализа городской клинической больницы № 40</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2004</year></pub-date><pub-date pub-type="epub"><day>10</day><month>03</month><year>2004</year></pub-date><volume>8</volume><issue>3</issue><fpage>48</fpage><lpage>51</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Жданова Т.В., Назаров А.В., Шалаев В.А., Мелях С.Ф., 2004</copyright-statement><copyright-year>2004</copyright-year><copyright-holder xml:lang="ru">Жданова Т.В., Назаров А.В., Шалаев В.А., Мелях С.Ф.</copyright-holder><copyright-holder xml:lang="en">Zhdanova T.V., Nazarov A.V., Shalaev V.A., Melyakh S.F.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/850">https://journal.nephrolog.ru/jour/article/view/850</self-uri><abstract><p>ЦЕЛЬЮ ИССЛЕДОВАНИЯ явилось изучение взаимосвязи между уровнем липидов крови и функцией эндотелия у больных с хронической почечной недостаточностью (ХПН). ПАЦИЕНТЫ И МЕТОДЫ. В исследуемой группе были пациенты с хроническим пиелонефритом и гипертоническим вариантом гломерулонефрита. Из них 25 больных с нормальной функцией почек, 58 с додиализной стадией ХПН, и 27 – с терминальной ХПН, получающих заместительную терапию гемодиализом (ГД). У всех больных наблюдалась артериальная гипертензия. Все пациенты получали адекватную гипотензивную терапию. У больных исследуемой группы отсутствовали клинические симптомы ишемической болезни сердца (ИБС) или атеросклероза церебральных артерий; признаки обострения основного заболевания почек или сопутствующей патологии; ГД был адекватным (sKt/V&gt;1,2). Определяли холестерин, холестерин липопротеидов низкой плотности (ХС ЛПНП), холестерин липопротеидов высокой плотности (ХС ЛПВП), триглицериды; эндотелийзависимую вазодилятацию (ЭЗВ) и эндотелийнезависимую вазодилятацию (ЭНВ). РЕЗУЛЬТАТЫ. Общий холестерин был несколько повышен в группах пациентов без ХПН и с додиализной стадией ХПН, а в группе ГД больных был в пределах нормы. Средние значения ХС ЛПНП, ХС ЛПВП, триглицеридов были в пределах нормы. Была получена достоверная отрицательная корреляционная взаимосвязь между ЭЗВ и уровнем триглицеридов крови. Не было выявлено достоверных корреляционных взаимосвязей с общим холестерином, ХС ЛПНП, ХС ЛПВП. Определена достоверная положительная взаимосвязь между ЭНВ и ХС ЛПВП, обладающим антиатерогенными свойствами. Не было выявлено взаимосвязей ЭНВ с уровнем холестерина и ХС ЛПНП. ЗАКЛЮЧЕНИЕ. В результате можно предположить, что триглицериды являются фактором, влияющим на развитие дисфункции эндотелия у больных с различной стадией ХПН, а ХС ЛПВП оказывают протективное действие на эндотелий.</p></abstract><trans-abstract xml:lang="en"><p>THE AIM of the work was to study the interrelationship between the blood lipid level and endothelium function in patients with chronic renal failure (CRF). PATIENTS AND METHODS. The group under study included patients with chronic pyelonephritis and hypertension variant of glomerulonephritis: 25 of them had normal function of the kidneys, 58 had predialysis stage of CRF and 27 had the endstage CRF receiving substitution therapy with hemodialysis (HD). All the patients had arterial hypertension. They received adequate hypotensive therapy. The patients under study had no clinical symptoms of ischemic heart disease (IHD) or atherosclerosis of the cerebral arteries, signs of exacerbation of the main kidney disease or coexistent pathology. HD was adequate (sKt/V&gt;1.2). Cholesterol, low density lipoprotein cholesterol (LDLPC), high density lipoprotein cholesterol (HDLPC), triglycerides, endotheliumdependent vasodilatation (EDV) and endotheliumindependent vasodilatation (EIV) were determined. RESULTS. General cholesterol was somewhat higher in patients without CRF and with the predialysis stage of CRF, while in the group of HD patients it was within the normal. Mean values of LDLPC and HDLPC, triglycerides were within the normal. Reliable negative correlative interrelation was noted between EDV and blood triglyceride level. No reliable correlative interrelation was noted with general cholesterol, LDLPC and HDLPC. Reliable positive interrelation was detected between EIV and LDLPC having antiatherogenic properties. No relationships were detected between EIV and cholesterol level and LDLPC. CONCLUSION. It can be suggested that triglycerides represent the factor influencing the development of endothelial dysfunction in patients with different stages of CRF, while LDLPC have protective effects on the endothelium.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>дисфункция эндотелия</kwd><kwd>липиды</kwd><kwd>хроническая почечная недостаточность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>endothelial dysfunction</kwd><kwd>lipids</kwd><kwd>chronic renal failure</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Celermajer DS, Sorensen KE, Spiegelhalter DJ et al. Aging is associated with endothelial dysfunction in healthy men years before the agerelated decline in women. J Am Coll Cardiol 1994;(24):471476</mixed-citation><mixed-citation xml:lang="en">Celermajer DS, Sorensen KE, Spiegelhalter DJ et al. Aging is associated with endothelial dysfunction in healthy men years before the agerelated decline in women. J Am Coll Cardiol 1994;(24):471476</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Celemajer DS, Adams MR, Clarcson P еt. al. Passive smoking and impaired endothelium –dependent responses in humans. Am J Cardiol 1996;(93):13461353</mixed-citation><mixed-citation xml:lang="en">Celemajer DS, Adams MR, Clarcson P еt. al. Passive smoking and impaired endothelium –dependent responses in humans. Am J Cardiol 1996;(93):13461353</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Giannattasio C, Mngoni AA, Failla M. et. al. Impaired radial artery compliance in normotensive subject with familial hypercholesterolemia. Atherosclerosis 1996;(124):249260</mixed-citation><mixed-citation xml:lang="en">Giannattasio C, Mngoni AA, Failla M. et. al. Impaired radial artery compliance in normotensive subject with familial hypercholesterolemia. Atherosclerosis 1996;(124):249260</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Гогин ЕЕ. Курение, эндотелий и гипертоническая болезнь. Клиническая медицина 1998;(11):1013</mixed-citation><mixed-citation xml:lang="en">Гогин ЕЕ. Курение, эндотелий и гипертоническая болезнь. Клиническая медицина 1998;(11):1013</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Shinozaki K, Hirayama A, Nishio Y et al. Coronary endothelial dysfunction in the insulinresistant state is linked to abnormal pteridine metabolism and vascular oxidative stress. J Am Coll Cardiol 2001; 38(7):18211828</mixed-citation><mixed-citation xml:lang="en">Shinozaki K, Hirayama A, Nishio Y et al. Coronary endothelial dysfunction in the insulinresistant state is linked to abnormal pteridine metabolism and vascular oxidative stress. J Am Coll Cardiol 2001; 38(7):18211828</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Arcaro G, Cretti A, Balzano S et al. Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002; 105(5):576582</mixed-citation><mixed-citation xml:lang="en">Arcaro G, Cretti A, Balzano S et al. Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002; 105(5):576582</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ghiadoni L, Donald AE, Cropley M et al. Mental stress induces transient endothelial dysfunction in humans. Circulation 2000; 102(20): 24732478</mixed-citation><mixed-citation xml:lang="en">Ghiadoni L, Donald AE, Cropley M et al. Mental stress induces transient endothelial dysfunction in humans. Circulation 2000; 102(20): 24732478</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Al Suwaidi J, Higano ST, Holmes DR et al. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol 2001; 37(6): 15231528</mixed-citation><mixed-citation xml:lang="en">Al Suwaidi J, Higano ST, Holmes DR et al. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol 2001; 37(6): 15231528</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Liuba P, Karnani P, Pesonen E et al. Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein Eknockout mice. Circulation 2000; 102(9):1039 1044</mixed-citation><mixed-citation xml:lang="en">Liuba P, Karnani P, Pesonen E et al. Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein Eknockout mice. Circulation 2000; 102(9):1039 1044</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Fichtlscherer S, Rosenberger G, Walter DH et al. Elevated Creactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000; 102(9):10001006</mixed-citation><mixed-citation xml:lang="en">Fichtlscherer S, Rosenberger G, Walter DH et al. Elevated Creactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000; 102(9):10001006</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lundman P, Eriksson MJ, Stuhlinger M et al. Mildto moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J Am Coll Cardiol 2001;38(1):111116</mixed-citation><mixed-citation xml:lang="en">Lundman P, Eriksson MJ, Stuhlinger M et al. Mildto moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J Am Coll Cardiol 2001;38(1):111116</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bostom AG, Culleton BF. Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephrol 1999, 10(4):891900</mixed-citation><mixed-citation xml:lang="en">Bostom AG, Culleton BF. Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephrol 1999, 10(4):891900</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Vallance P, Leone A, Calver A et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; (339):572575</mixed-citation><mixed-citation xml:lang="en">Vallance P, Leone A, Calver A et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; (339):572575</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Joznnides R, Bakkali EN, Le Roy F et al. Altered flow dependent vasodilatation of conduct arteries in maintenance haemodialysis. Nephrol Dial Transpalant 1997;12: 2623 – 2628</mixed-citation><mixed-citation xml:lang="en">Joznnides R, Bakkali EN, Le Roy F et al. Altered flow dependent vasodilatation of conduct arteries in maintenance haemodialysis. Nephrol Dial Transpalant 1997;12: 2623 – 2628</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kari JA, Donald AE, Vallance DT et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 1997;52 (2):468472</mixed-citation><mixed-citation xml:lang="en">Kari JA, Donald AE, Vallance DT et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 1997;52 (2):468472</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kosch M, Levers A, Barenbrock M et al. Acute effects of haemodialysis on endothelial function and large artery elasticity. Nephrol Dial Transplant 2001; (16):16631668</mixed-citation><mixed-citation xml:lang="en">Kosch M, Levers A, Barenbrock M et al. Acute effects of haemodialysis on endothelial function and large artery elasticity. Nephrol Dial Transplant 2001; (16):16631668</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Yand MF, William GH, Webb DJ. Hemodialysis and L arginin, but not Darginin, correct renal failureassociated endothelial dysfunction. Kidney Int 1998; 53(4):10681077</mixed-citation><mixed-citation xml:lang="en">Yand MF, William GH, Webb DJ. Hemodialysis and L arginin, but not Darginin, correct renal failureassociated endothelial dysfunction. Kidney Int 1998; 53(4):10681077</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Затейщикова А.А,.Затейщиков Д.А. Эндотелиальная регуляция сосудистого тонуса: методы исследования и клиническое значение. Кардиология 1998;(9):68 – 80</mixed-citation><mixed-citation xml:lang="en">Затейщикова А.А,.Затейщиков Д.А. Эндотелиальная регуляция сосудистого тонуса: методы исследования и клиническое значение. Кардиология 1998;(9):68 – 80</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Насонов ЕЛ, Баранов АА. Маркеры активации эндотелия (тромбомодулин, антиген фактора Виллебранта и ангиотензинпревращающий фермент): клиническое значение. Клин мед 1998; (11): 4 – 7</mixed-citation><mixed-citation xml:lang="en">Насонов ЕЛ, Баранов АА. Маркеры активации эндотелия (тромбомодулин, антиген фактора Виллебранта и ангиотензинпревращающий фермент): клиническое значение. Клин мед 1998; (11): 4 – 7</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Boger RH, BodeBoger SM, Thiele W et al. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 1997;95(8):20682074</mixed-citation><mixed-citation xml:lang="en">Boger RH, BodeBoger SM, Thiele W et al. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 1997;95(8):20682074</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Quyyumi AA, Dakak N, Andrews NP et al. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest 1995; 95(4):17471755</mixed-citation><mixed-citation xml:lang="en">Quyyumi AA, Dakak N, Andrews NP et al. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest 1995; 95(4):17471755</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Lacy CR, Contrada RJ, Robbins ML et al. Coronary vasoconstriction induced by mental stress (simulated public speaking). Am J Cardiol 1995; 75(7): 503505</mixed-citation><mixed-citation xml:lang="en">Lacy CR, Contrada RJ, Robbins ML et al. Coronary vasoconstriction induced by mental stress (simulated public speaking). Am J Cardiol 1995; 75(7): 503505</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Halcox JP, Schenke WH, Zalos G et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106(6):653658</mixed-citation><mixed-citation xml:lang="en">Halcox JP, Schenke WH, Zalos G et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106(6):653658</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Cardillo C, Kilcoune CM, Cannon RO et al. Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilatator function in hypercholesterolemic but not in hypertensive patients. Hypertension 1997; (30):5763</mixed-citation><mixed-citation xml:lang="en">Cardillo C, Kilcoune CM, Cannon RO et al. Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilatator function in hypercholesterolemic but not in hypertensive patients. Hypertension 1997; (30):5763</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
